Clinical Trial

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up

Study acronym: ReActIF- LTO
Recruiting
View on ClinicalTrials.gov →
Summary
Subjects previously enrolled / randomized in the ReActIF-ICE (Recovery from acute immune failure in septic shock by immune cell extracorporeal terapy - immune competence enhancement) study received either standard sepsis treatment (control group) or standard sepsis treatment and additionally the ARTICE treatment (treatment group) during their index hospitalization. All subjects are followed up for 90 days after enrollment. In this long term follow up study, the enrolled subjects shall be followed up beyond 90 days for up to 5 years.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-20.
Trial Details
NCT Number NCT06143137
Lead Sponsor Artcline GmbH
Collaborators: ZKS Jena
Conditions Severe Sepsis
Enrollment 142 participants
Start Date 2024-01-01
Primary Completion 2029-12-31 (estimated)
Study Completion 2030-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-08-02